SCHEMBL97652

SCHEMBL97652

O=C1NC(=O)C(=Cc2ccc3c(c2)N(Cc2ccc(-c4ccccc4)cc2)C(=O)CC3)S1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.53
▸ PIK3CG P48736 1/20 0.50
▸ PTPN1 P18031 4/20 0.49
▸ BRD4 O60885 1/20 0.48
▸ PIM1 P11309 2/20 0.48
▸ PIM2 Q9P1W9 2/20 0.48
▸ PIM3 Q86V86 1/20 0.48
▸ GLS O94925 1/20 0.48
▸ GLS2 Q9UI32 1/20 0.48
▸ NAT1 P18440 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ MGAM O43451 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ SI P14410 1/20 0.46
▸ MGAM2 Q2M2H8 1/20 0.46
▸ PPARG P37231 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ AADAT Q8N5Z0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97651 1.00 HPGD (0.53) HPGDPIK3CGPTPN1BRD4PIM1
SCHEMBL98152 0.81 PTPN1 (0.48) HPGDPTPN1PIM1PIM2PIM3
SCHEMBL98151 0.81 PTPN1 (0.48) HPGDPTPN1PIM1PIM2PIM3
SCHEMBL1248780 0.76 PIM1 (0.83) HPGDPIK3CGPTPN1PIM1PIM2
SCHEMBL12891790 0.76 PIM1 (0.83) HPGDPIK3CGPTPN1PIM1PIM2
SCHEMBL1248782 0.76 PIM1 (0.83) HPGDPIK3CGPTPN1PIM1PIM2
SCHEMBL5339477 0.75 PIK3CG (0.83) PIK3CG
SCHEMBL8148705 0.75 MGAM (0.56) HPGDPTPN1PIM1PIM2PIM3
SCHEMBL8148703 0.75 MGAM (0.56) HPGDPTPN1PIM1PIM2PIM3
SCHEMBL2877647 0.75 PIK3CG (0.83) PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 — — US disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 — — EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 — — US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 — — US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 HPGD 2322/4885PIK3CG 3965/4885PTPN1 1691/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 HPGD 2322/4885PIK3CG 3965/4885PTPN1 1691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback